Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 18, 2021 - Issue 5
Submit an article Journal homepage
317
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Needle-free jet injection of insulin glargine improves glycemic control in patients with type 2 diabetes mellitus: a study based on the flash glucose monitoring system

Xiaocen KongDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Jiangsu, ChinaView further author information
,
Menghui LuoDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Jiangsu, ChinaView further author information
,
Ling CaiDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Jiangsu, ChinaView further author information
,
Peng ZhangDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Jiangsu, ChinaView further author information
,
Rengna YanDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Jiangsu, ChinaView further author information
,
Yun HuDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Jiangsu, ChinaView further author information
,
Huiqin LiDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Jiangsu, ChinaCorrespondence[email protected]
View further author information
&
Jianhua MaDepartment of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Jiangsu, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 635-641 | Received 16 Jun 2020, Accepted 10 Dec 2020, Published online: 19 Feb 2021

References

  • Zinman B. The international diabetes federation world diabetes congress 2015. Eur Endocrinol. 2015 Aug;11(2):66.
  • Hu C, Jia W. Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes. 2018 Jan;67(1):3–11.
  • Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010 Mar 25;362(12):1090–1101.
  • Ruan Y, Yan QH, Xu JY, et al. Epidemiology of diabetes in adults aged 35 and older from Shanghai, China. Biomedical and Environmental Sciences. 2016 June;29(6):408–416.
  • Egede LE, Gebregziabher M, Dismuke CE, et al. Medication nonadherence in diabetes: longitudinal effects on costs and potential cost savings from improvement. Diabetes Care. 2012 Dec;35(12):2533–2539.
  • Bragg F, Holmes MV, Iona A, et al. Association between diabetes and cause-specific mortality in rural and urban areas of China. JAMA. 2017 Jan 17;317(3):280–289.
  • Mata-Cases M, Rodriguez-Sanchez B, Mauricio D, et al. The association between poor glycemic control and health care costs in people with diabetes: a population-based study. Diabetes Care. 2020 Apr;43(4):751–758.
  • Pan C, Yang W, Jia W, et al. Management of Chinese patients with type 2 diabetes, 1998–2006: the Diabcare-China surveys. Curr Med Res Opin. 2009 Jan;25(1):39–45.
  • Miao R, Wei W, Lin J, et al. Does device make any difference? A real-world retrospective study of insulin treatment among elderly patients with type 2 diabetes. J Diabetes Sci Technol. 2014 Jan;8(1):150–158.
  • Guerci B, Chanan N, Kaur S, et al. Lack of treatment persistence and treatment nonadherence as barriers to glycaemic control in patients with type 2 diabetes. Diabetes Therapy. 2019 Apr;10(2):437–449.
  • Ji J, Lou Q. Insulin pen injection technique survey in patients with type 2 diabetes in mainland China in 2010. Curr Med Res Opin. 2014 June;30(6):1087–1093.
  • Mitragotri S. Current status and future prospects of needle-free liquid jet injectors. Nat Rev Drug Discov. 2006 July;5(7):543–548.
  • de Wit HM, Engwerda EE, Tack CJ, et al. Insulin administered by needle-free jet injection corrects marked hyperglycaemia faster in overweight or obese patients with diabetes. Diabetes Obes Metab. 2015 Nov;17(11):1093–1099.
  • Engwerda EE, Tack CJ, de Galan BE. Needle-free jet injection of rapid-acting insulin improves early postprandial glucose control in patients with diabetes. Diabetes Care. 2013 Nov;36(11):3436–3441.
  • Xing Y, Xie X, Xu J, et al. Efficacy and safety of a needle-free injector in Chinese patients with type 2 diabetes mellitus treated with basal insulin: a multicentre, prospective, randomised, crossover study. Expert Opin Drug Deliv. 2019 Sep;16(9):995–1002.
  • Guo L, Xiao X, Sun X, et al. Comparison of jet injector and insulin pen in controlling plasma glucose and insulin concentrations in type 2 diabetic patients. Medicine (Baltimore). 2017 Jan;96(1):e5482.
  • Furler J, O’Neal D, Speight J, et al. Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trial. Lancet Diabetes Endocrinol. 2020 Jan;8(1):17–26.
  • Sun Y, Wang J, Li H, et al. Comparison of glucose variability in patients with type 2 diabetes administrated glargine with needle-free jet injector and conventional insulin pen. Expert Opin Drug Deliv. 2020;12:1–5.
  • Baxter J, Mitragotri S. Needle-free liquid jet injections: mechanisms and applications. Expert Rev Med Devices. 2006 Sep;3(5):565–574.
  • Engwerda EE, Abbink EJ, Tack CJ, et al. Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology. Diabetes Care. 2011 Aug;34(8):1804–1808.
  • Hu J, Shi H, Zhao C, et al. Lispro administered by the QS-M needle-free jet injector generates an earlier insulin exposure. Expert Opin Drug Deliv. 2016 Sep;13(9):1203–1207.
  • Goykhman S, Drincic A, Desmangles JC, et al. Insulin glargine: a review 8 years after its introduction. Expert Opin Pharmacother. 2009 Mar;10(4):705–718.
  • Lucidi P, Porcellati F, Candeloro P, et al. Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: a dose-response study. Nutr Metab Cardiovasc Dis. 2014 July;24(7):709–716.
  • Engwerda EEC, Tack CJ, de Galan BE. Pharmacokinetic and pharmacodynamic variability of insulin when administered by jet injection. J Diabetes Sci Technol. 2017 Sep;11(5):947–952.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.